About this event

  • Date and time Fri 1 Feb 2019 from 1:30pm to 4:30pm
  • Location Royal Society of Medicine
  • Organised by Laryngology and Rhinology

Registrations are now closed.

Join us as we discuss and debate hot topics in laryngology. You'll better understand the practices of experienced clinicians in areas which remain open to debate.

Are you for, or against? 

  • The de-escalation of thyroid cancer management
  • Minimally invasive surgery for parotid tumours

Professor Hisham Mehanna and Mr Ricard Simo shall supervise the debates on two important areas of current thyroid and salivary gland practice and ask the audience for their views before and after the presentations.

Key speakers

Chair: Professor Hisham Mehanna,

Chair of Head and Neck Surgery, Institute of Cancer and Genomic Sciences

Mr James England

Consultant ENT Surgeon, Spire Hull and East Riding Hospital

Mr Iain Nixon

Ear, Nose and Throat Surgeon, NHS Lothian

Mr Ricard Simo

Consultant Otorhinolaryngologist Head and Neck Surgeon, Guy’s and St Thomas’ NHS Foundation Trust

Professor Mark McGurk

Consultant Oral and Maxillofacial and Head and Neck Surgeon, University College London Hospitals NHS Foundation Trust

Mr Paul Pracy

Consultant ENT Surgeon, University Hospitals Birmingham NHS Foundation Trust

Agenda

View the programme

Registration, tea and coffee
Welcome and introduction
Debate: Minimally invasive surgery for parotid tumours

Chair: Mr Ricard Simo, Consultant Otorhinolaryngologist Head and Neck Surgeon, Guy’s and St Thomas’ NHS Foundation Trust

For: Minimally invasive surgery for parotid tumours

Professor Mark McGurk, Consultant Oral and Maxillofacial and Head and Neck Surgeon, University College London Hospitals NHS Foundation Trust

Against: Minimally invasive surgery for parotid tumours

Mr Paul Pracy, Consultant ENT Surgeon, University Hospitals Birmingham NHS Foundation Trust

For: Reply
Against: Reply
Conclusions
Tea and coffee break
Debate: The de-escalation of thyroid cancer management will result in worsening outcomes

Chair: Professor Hisham Mehanna, Chair of Head and Neck Surgery, Institute of Cancer and Genomic Sciences

For: The de-escalation of thyroid cancer management will result in worsening outcomes

Mr James England, Consultant ENT Surgeon, Spire Hull and East Riding Hospital

Against: The de-escalation of thyroid cancer management will result in worsening outcomes

Mr Iain Nixon, Ear, Nose and Throat Surgeon, NHS Lothian

For: Reply
Against: Reply
Conclusions
Closing remarks
Close of meeting

Location

Royal Society of Medicine, 1 Wimpole St,, Marylebone, London, London, W1G 0AE, United Kingdom